Cholestyramine

Product NDC
0832-0536
11-digit product format
008320536
Labeler code
0832
Product ID
0832-0536_c5478552-9a0f-436e-bc77-d0e8436bcfb9
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Cholestyramine
Dosage form
POWDER, FOR SUSPENSION
Route
ORAL
Labeler
Upsher-Smith Laboratories,LLC
Application
ANDA214877
Marketing category
ANDA
Marketing start
2022-01-21
Marketing end
0000-00-00
Substance
CHOLESTYRAMINE
Active strength
4 g/9g
Pharmacologic classes
Bile Acid Sequestrant [EPC], Bile-acid Binding Activity [MoA]
NDC exclude flag
No
Listing certified through
2023-12-31
Current FDA listing
Historical FDA.report record

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
0832-0536CHOLESTYRAMINE POWDER, FOR SUSPENSION [UPSHER-SMITH LABORATORIES,LLC]4Legacy NDC20230526_c378f531-b27a-47dd-889f-0c8338c123df.zip

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
0832-0536-420083205364242 POUCH in 1 CARTON (0832-0536-42) > 9 g in 1 POUCH (0832-0536-89) 42 pouch2022-01-210000-00-00NoNoCurrent
0832-0536-600083205366060 CAN in 1 CARTON (0832-0536-60) > 378 g in 1 CAN (0832-0536-37) 60 can2022-01-210000-00-00NoNoCurrent